Progyny, Inc. Other Current Liabilities
Progyny, Inc. (PGNY) had Other Current Liabilities of $1.91 million as of 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2026-02-27
- 2025-12-31: Other Liabilities, Current $1.91M.
- 2024-12-31: Other Liabilities, Current $5.30M.
- 2023-12-31: Other Liabilities, Current $1.18M.
- 2022-12-31: Other Liabilities, Current $1.17M.
| Period end | Other Liabilities, Current |
|---|---|
| 2025-12-31 | $1.91M 10-K · filed 2026-02-27 |
| 2024-12-31 | $5.30M 10-K · filed 2026-02-27 |
| 2023-12-31 | $1.18M 10-K · filed 2025-03-03 |
| 2022-12-31 | $1.17M 10-K · filed 2024-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |